Task: Answer the MCQ question.
Question: Which compound exhibits a -33.782% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a) Cc1ccc(NC(=O)N2CCN(Cc3ccc4c(c3)OCO4)CC2)cc1
b) COc1ccc(OC)c(/C=C/C(=O)OCC(=O)NCc2ccco2)c1
Answer: a. Cc1ccc(NC(=O)N2CCN(Cc3ccc4c(c3)OCO4)CC2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(NC(=O)N2CCN(Cc3ccc4c(c3)OCO4)CC2)cc1
Cc1ccc(NC(=O)N2CCN(Cc3ccc4c(c3)OCO4)CC2)cc1
4-(1,3-benzodioxol-5-ylmethyl)-N-(4-methylphenyl)piperazine-1-carboxamide